Significant agreements (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of collaboration receivables and contract liabilities

	Balance at						Balance at
	December 31, 2022		Additions		Deductions		September 30, 2023
		(in thousands)
Related party collaboration receivable	$	-	$	4,364	$	(2,445)	$	1,919
Contract liabilities:
Deferred revenue	$	-	$	74,420	$	(1,643)	$	72,777

Neurocrine Collaboration Agreement

Schedule of allocation of variable consideration

Performance Obligation	Amount
	(in thousands)
Variable Consideration
GBA1 Program	$	6,189
2023 Discovery Program 1		3,417
2023 Discovery Program 2		2,354
2023 Discovery Program 3		1,292
Total	$	13,252

Schedule of allocation of fixed consideration

Performance Obligation	Amount
	(in thousands)
Fixed Consideration
GBA1 Program	$	69,459
2023 Discovery Program 1		24,807
2023 Discovery Program 2		24,807
2023 Discovery Program 3		24,807
Total	$	143,880